Selling a healthcare business is not like selling a restaurant or a software company. The combination of regulatory requirements, patient data obligations, licensing transfers, and payer contracts creates a transaction process that can take 12 to 24 months from start to close.
Owners who understand this going in tend to get better outcomes than those who treat it like a standard M&A deal. This guide covers the key steps, from preparing your business for market to negotiating final deal terms.
Key Takeaways
- Healthcare deals require regulatory and licensure planning well before you go to market.
- Your EBITDA multiple depends heavily on payer mix, patient volume trends, and compliance history.
- The right buyer type, whether strategic or private equity, will shape both price and transition expectations.
Know What You're Actually Selling
Before approaching any buyer, you need to be clear on the legal structure of the transaction. Most healthcare deals are structured as either an asset purchase or a stock purchase.
Asset purchases are more common because they allow the buyer to cherry-pick specific assets and avoid assuming unknown liabilities.
Stock purchases transfer ownership of the entire legal entity, liabilities included, which buyers typically require a discount for.
If your practice operates under a Professional Corporation (PC) or Professional Limited Liability Company (PLLC), the structure gets more complicated.
Many states prohibit non-physicians from owning these entities, which is why private equity buyers often use a management services organization (MSO) model to acquire the business operations while a physician-owned entity retains clinical control on paper.
This is worth understanding early because it affects how you negotiate and what documents you'll be signing.
What Buyers Are Actually Looking At
Buyers, particularly PE-backed platforms, run a fairly consistent playbook when evaluating healthcare businesses. Here's what gets scrutinized most closely:
| Factor | Why It Matters |
|---|---|
| EBITDA margin | Baseline for valuation multiples; typical healthcare deals range from 5x to 12x EBITDA depending on specialty |
| Payer mix | Higher commercial insurance revenue is more valuable than Medicaid-heavy books |
| Revenue concentration | If one physician generates 60%+ of revenue, buyers see a flight risk |
| Compliance history | OIG exclusions, billing audits, or HIPAA breaches can kill or reprice a deal |
| Credentialing and contracts | Payer contracts often require assignment consent, which takes time |
| Patient volume trends | Three-year growth signals stability; declining volume triggers earn-out structures |
Multiples in 2024 varied by specialty. Behavioral health and primary care have seen compression compared to their 2021 peaks, while dermatology, ophthalmology, and gastroenterology have held up better.
Specialty practices with ancillary revenue (labs, imaging, ASC ownership) typically command higher multiples than single-service providers.
Preparing Your Business Before It Goes to Market
Most owners start thinking about selling too late. Two years is a reasonable lead time to actually optimize what's under the hood.
Start with your financials. Get them on accrual basis if they aren't already. Clean up any personal expenses run through the business.
If you've been paying family members above-market salaries, document the adjustments clearly in your add-back schedule. Buyers and their accountants will dig into every line item.
Compliance is the other area where early preparation pays off. Commission an independent compliance audit before you hire a banker.
You want to identify problems on your own timeline, not during due diligence when the buyer is using every finding as leverage to reduce price.
Common issues include improper billing codes, incomplete documentation, and outdated HIPAA policies.
- Organize three to five years of tax returns, financial statements, and payroll records
- Document all payer contracts and their assignability provisions
- Get current on credentialing renewals for all providers
- Review any outstanding malpractice claims or regulatory actions
- Make sure your corporate minutes and governance documents are current
Choosing the Right Type of Buyer
Not all buyers want the same thing, and understanding the difference matters for your transition and your price.
Private equity buyers are usually building platforms. They want to acquire, integrate, and eventually sell to a larger buyer or take public.
They'll often ask you to roll over 20 to 40 percent of your equity into the new entity, which means you participate in a second bite of the apple if the platform grows.
The downside is loss of autonomy. Post-close, you'll have reporting structures, KPIs, and revenue cycle teams you didn't have before.
Strategic buyers, meaning health systems, hospital groups, or larger group practices, typically offer less in price but more in operational resources.
Employment agreements post-close tend to be longer and more restrictive. These buyers often move slower through due diligence because of internal committee approvals.
Individual buyers and physician groups are a third option, usually for smaller practices.
They may pay less but offer more flexibility on deal structure and transition timelines. Seller financing is more common in these transactions.
The Process, From LOI to Close
Once you've engaged a healthcare-focused M&A advisor and created a confidential information memorandum (CIM), the process typically looks like this:
- Marketing phase: The advisor contacts qualified buyers under NDA, collects indications of interest, and narrows to a shortlist
- Management presentations: You meet with serious buyers in person or virtually to walk through the business
- Letter of Intent (LOI): The leading buyer submits a non-binding offer outlining price, structure, and key terms
- Due diligence: A 60 to 90 day process covering financial, legal, clinical, and operational review
- Definitive agreement: The purchase agreement is negotiated and executed
- Regulatory approvals and licensure transfers: State and federal notifications, CON filings if applicable, and payer contract assignments
- Close and transition: Funds transfer, operational handoff, and typically a post-close employment or consulting period
The LOI stage is where many sellers lose leverage. Once you sign an LOI and enter exclusivity, your negotiating power shrinks.
A buyer who initially offered 8x EBITDA can chip away through due diligence findings, working capital adjustments, and indemnification carve-outs.
Push to negotiate key terms before exclusivity, not after.
Tax Planning Shouldn't Be an Afterthought
The structure of your deal has significant tax consequences. Asset sales generally produce ordinary income on certain asset classes (like accounts receivable and non-compete agreements) and capital gains on others.
Stock sales are taxed at capital gains rates, which is one reason sellers prefer them.
If you've owned the business for years and have a low-cost basis, the tax hit can be substantial. Work with a tax advisor experienced in healthcare transactions before you sign anything.
Installment sales, charitable remainder trusts, and opportunity zone investments are among the strategies worth exploring depending on your situation.
Conclusion
Selling a healthcare business rewards owners who prepare early, understand what buyers actually care about, and get the right advisors in place before going to market.
The process is long and detail-intensive, but the financial and personal outcomes are materially better for those who treat preparation as part of the strategy, not an afterthought.